These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 17496511)

  • 1. A preliminary report--heparin counteracts indomethacin effect on ductus arteriosus in very low birthweight infants.
    Ojala TH; Lehtonen L
    Pediatr Crit Care Med; 2007 May; 8(3):258-60. PubMed ID: 17496511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants.
    Cordero L; Nankervis CA; Gardner D; Giannone PJ
    J Perinatol; 2007 Jan; 27(1):22-7. PubMed ID: 17053778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of sterile water by gavage drip in the fluid management of extremely low birth weight infants.
    Stewart CD; Morris BH; Huseby V; Kennedy KA; Moya FR
    J Perinatol; 2009 Jan; 29(1):26-32. PubMed ID: 18754014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of indomethacin on closure of ductus arteriosus in very-low-birthweight neonates.
    Godambe S; Newby B; Shah V; Shah PS
    Acta Paediatr; 2006 Nov; 95(11):1389-93. PubMed ID: 17062465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical aspects of very-low-birthweight infants showing reopening of ductus arteriosus.
    Uchiyama A; Nagasawa H; Yamamoto Y; Tatebayashi K; Suzuki H; Yamada K; Arai M; Kohno Y
    Pediatr Int; 2011 Jun; 53(3):322-7. PubMed ID: 20854286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrauterine inflammation as a risk factor for persistent ductus arteriosus patency after cyclooxygenase inhibition in extremely low birth weight infants.
    Kim ES; Kim EK; Choi CW; Kim HS; Kim BI; Choi JH; Park JS; Moon KC
    J Pediatr; 2010 Nov; 157(5):745-50.e1. PubMed ID: 20598319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin.
    Itabashi K; Ohno T; Nishida H
    J Pediatr; 2003 Aug; 143(2):203-7. PubMed ID: 12970633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patent ductus arteriosus in very low birthweight infants: complications of pharmacological and surgical treatment.
    Koehne PS; Bein G; Alexi-Meskhishvili V; Weng Y; Bührer C; Obladen M
    J Perinat Med; 2001; 29(4):327-34. PubMed ID: 11565202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous indomethacin infusion may be less effective than bolus infusions for ductal closure in very low birth weight infants.
    de Vries NK; Jagroep FK; Jaarsma AS; Elzenga NJ; Bos AF
    Am J Perinatol; 2005 Feb; 22(2):71-5. PubMed ID: 15731984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population-based study.
    Dollberg S; Lusky A; Reichman B
    J Pediatr Gastroenterol Nutr; 2005 Feb; 40(2):184-8. PubMed ID: 15699694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High efficacy and minor renal effects of indomethacin treatment during individualized fluid intake in premature infants with patent ductus arteriosus.
    Leonhardt A; Strehl R; Barth H; Seyberth HW
    Acta Paediatr; 2004 Feb; 93(2):233-40. PubMed ID: 15046280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment strategies to prevent or close a patent ductus arteriosus in preterm infants and outcomes.
    Laughon M; Bose C; Clark R
    J Perinatol; 2007 Mar; 27(3):164-70. PubMed ID: 17251985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of ductal closure and intestinal complications in very low birth weight infants treated with indomethacin.
    Madan J; Fiascone J; Balasubramanian V; Griffith J; Hagadorn JI
    Neonatology; 2008; 94(1):45-51. PubMed ID: 18196930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of ductal diameter on surgical and medical closure of patent ductus arteriosus in preterm neonates: size matters.
    Tschuppert S; Doell C; Arlettaz-Mieth R; Baenziger O; Rousson V; Balmer C; Prêtre R; Dodge-Khatami A
    J Thorac Cardiovasc Surg; 2008 Jan; 135(1):78-82. PubMed ID: 18179922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of ibuprofen in neonates in the treatment of patent ductus arteriosus.
    Van Overmeire B
    Int J Clin Pract Suppl; 2003 Apr; (135):23-7. PubMed ID: 12723743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is oral indomethacin effective in treatment of preterm infants with patent ductus arteriosus?
    Satar M; Yapicioğlu H; Narli N; Ozbarlas N; Küçükosmanoğlu O; Tutak E
    Turk J Pediatr; 2004; 46(2):137-41. PubMed ID: 15214742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orogastric and intravenous indomethacin administration to very premature neonates with patent ductus arteriosus: population pharmacokinetics, absolute bioavailability, and treatment outcome.
    Al Za'abi M; Donovan T; Tudehope D; Woodgate P; Collie LA; Charles B
    Ther Drug Monit; 2007 Dec; 29(6):807-14. PubMed ID: 18043480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II type 1 receptor A1166C polymorphism and prophylactic indomethacin treatment induced ductus arteriosus closure in very low birth weight neonates.
    Treszl A; Szabo M; Dunai G; Nobilis A; Kocsis I; Machay T; Tulassay T; Vasarhelyi B
    Pediatr Res; 2003 Nov; 54(5):753-5. PubMed ID: 12904590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indomethacin therapy for patent ductus arteriosus in premature infants: efficacy of a dosing strategy based on a second-dose peak plasma indomethacin level and estimated plasma indomethacin levels.
    O'Donovan DJ; Fernandes CJ; Nguyen NY; Adams K; Adams JM
    Am J Perinatol; 2004 May; 21(4):191-7. PubMed ID: 15168317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased plasma glucose following indomethacin therapy in premature infants with patent ductus arteriosus.
    Lilien LD; Srinivasan G; Yeh TF; Pildes RS
    Pediatr Pharmacol (New York); 1985; 5(1):73-7. PubMed ID: 3887313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.